European evidence based consensus on the diagnosis and management of Crohn's disease: special situations
- PMID: 16481630
- PMCID: PMC1859996
- DOI: 10.1136/gut.2005.081950c
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations
Abstract
This third section of the European Crohn's and Colitis Organisation (ECCO) Consensus on the management of Crohn's disease concerns postoperative recurrence, fistulating disease, paediatrics, pregnancy, psychosomatics, extraintestinal manifestations, and alternative therapy. The first section on definitions and diagnosis reports on the aims and methods of the consensus, as well as sections on diagnosis, pathology, and classification of Crohn's disease. The second section on current management addresses treatment of active disease, maintenance of medically induced remission, and surgery of Crohn's disease.
References
-
- Caprilli R, Andreoli A, Capurso L, Gruppo Italiano per lo Studio del Colon e del Retto (GISC) et al Oral mesalazine (5‐aminosalicylic acid; Asacol) for the prevention of post‐operative recurrence of CD. Aliment Pharmacol Ther 1994835–43. - PubMed
-
- Whelan G, Farmer R G, Fazio V W, Goormastic M. Recurrence after surgery in Crohn's disease. Gastroenterology 1985881826–1833. - PubMed
-
- Tytgat G N J, Mulder C J J, Brummelkamp W H. Endoscopic lesions in Crohn's disease early after ileocecal resection. Endoscopy 198820260–262. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical